|
ATYR aTyr Pharma Inc 1339970 |
| Balance Sheet |
|
Current Assets
|
$58,362,000.00 |
|
Assets
|
$69,825,000.00 |
|
Current Liabilities
|
$11,396,000.00 |
|
Equity
|
$48,788,000.00 |
|
Shares Out
|
98087425.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-21,868,000.00 |
|
Investing Cash Flow
|
$26,816,000.00 |
| Market Analysis |
Market Cap
|
$49,043,712.50 |
|
Price
|
$0.50 |
|
BVPS
|
0.50 |
|
PB
|
1.00 |
|
EPS
|
-0.11 |
|
PS
|
258.12 |
|
FCF
|
$-22,079,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:55 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:45 |
|
| Apr |
May |
Jun |
| 2026-03-05 |
-0.14 |
|
|
2026-05-15 |
-0.11 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
-0.22 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-0.26 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ATYR documents filed with the SEC.
ATYR Filings
Clear
